ZimVie (NASDAQ:ZIMV) Releases FY 2024 Earnings Guidance

ZimVie (NASDAQ:ZIMV) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 0.550-0.700 for the period, compared to the consensus EPS estimate of 0.590. The company issued revenue guidance of $450.0 million-$460.0 million, compared to the consensus revenue estimate of $453.9 million.

Analyst Ratings Changes

Separately, Needham & Company LLC increased their price objective on shares of ZimVie from $20.00 to $23.00 and gave the company a buy rating in a report on Friday.

ZimVie Price Performance

Shares of ZimVie stock traded down $3.10 during midday trading on Friday, hitting $17.30. 1,723,003 shares of the company were exchanged, compared to its average volume of 426,869. The firm has a 50 day simple moving average of $18.05 and a 200-day simple moving average of $17.54. ZimVie has a 52 week low of $6.52 and a 52 week high of $22.40. The firm has a market cap of $472.12 million, a P/E ratio of -1.24 and a beta of 2.18. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.68 and a quick ratio of 2.23.

ZimVie (NASDAQ:ZIMV) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $116.81 million for the quarter. ZimVie had a positive return on equity of 2.09% and a negative net margin of 63.84%. During the same quarter in the prior year, the business earned $0.17 earnings per share. Research analysts forecast that ZimVie will post 0.63 earnings per share for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.